Cargando…
Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells
Autores principales: | Pani, Trishna, Rajput, Kajal, Kar, Animesh, Dasgupta, Ujjaini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057095/ https://www.ncbi.nlm.nih.gov/pubmed/33884288 http://dx.doi.org/10.18632/oncoscience.531 |
Ejemplares similares
-
Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype
por: Pani, Trishna, et al.
Publicado: (2021) -
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
por: Rajput, Kajal, et al.
Publicado: (2022) -
CERS6 required for cell migration and metastasis in lung cancer
por: Suzuki, Motoshi, et al.
Publicado: (2020) -
Autophagy regulation by RNA alternative splicing and implications in human diseases
por: González-Rodríguez, Patricia, et al.
Publicado: (2022) -
Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing
por: Piazzi, Manuela, et al.
Publicado: (2023)